Lepu Biopharma Co. Ltd. Class H (HK:2157) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Lepu Biopharma Co., Ltd. has announced a proposed change of auditor, with PricewaterhouseCoopers resigning and the company planning to appoint Ernst & Young as its new auditor for 2024. This transition, recommended by the Audit Committee, is pending approval at the upcoming extraordinary general meeting and is based on Ernst & Young’s industry experience and market reputation.
For further insights into HK:2157 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue